68Ga-XACP3 PET/CT in Prostate Cancer

计划入组 60 人 · 首次发布于 2025 年 11 月 21 日

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

计划入组 22 人 · 首次发布于 2007 年 12 月 28 日

Omega 3 Fatty Acid Trial

计划入组 19 人 · 首次发布于 2008 年 1 月 4 日

Alkaline Phosphatase

3',3-diselenodipropionic acid

C₆H₁₀O₄Se₂

3-phenylpropionic acid

C₉H₁₀O₂

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

Bristol Myers Squibb Subsidiary RayzeBio Acquires OncoACP3 Radiopharmaceutical for Prostate Cancer in $1.35 Billion Deal

Esperion Advances Bempedoic Acid to Phase 3 Trials for Pediatric Familial Hypercholesterolemia

FDA Approves Expanded Use of Biofrontera's Ameluz for Actinic Keratosis Treatment